Acrocyanosis: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) No edit summary |
|||
(12 intermediate revisions by 3 users not shown) | |||
Line 4: | Line 4: | ||
Image = Acrocyanosis 0001.jpg| | Image = Acrocyanosis 0001.jpg| | ||
Caption = Hand: Acrocyanosis: Gross, an excellent example <br> <small> [http://www.peir.net Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology] </small>| | Caption = Hand: Acrocyanosis: Gross, an excellent example <br> <small> [http://www.peir.net Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology] </small>| | ||
}} | }} | ||
{{ | {{Acrocyanosis}} | ||
'''For patient information, click [[Acrocyanosis (patient information)|here]]''' | |||
{{CMG}} | {{CMG}} | ||
Line 18: | Line 13: | ||
{{SK}} Cassirer syndrome; Crocq disease | {{SK}} Cassirer syndrome; Crocq disease | ||
==Overview== | ==[[Acrocyanosis overview|Overview]]== | ||
== | ==[[Acrocyanosis historical perspective|Historical Perspective]]== | ||
==[[Acrocyanosis classification|Classifications]]== | |||
==Pathophysiology | ==[[Acrocyanosis pathophysiology|Pathophysiology]]== | ||
==[[Acrocyanosis causes|Causes]]== | |||
== | ==[[Acrocyanosis differential diagnosis|Differentiating Acrocyanosis from other Disorders]]== | ||
== | ==[[Acrocyanosis epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Acrocyanosis risk factors|Risk Factors]]== | |||
==[[Acrocyanosis screening|Screening]]== | |||
==[[Acrocyanosis natural history, complications and prognosis|Natural History, Complications, and Prognosis]]== | |||
==Diagnosis== | |||
[[Acrocyanosis history and symptoms|History and Symptoms]] | [[Acrocyanosis physical examination|Physical Examination]] | [[Acrocyanosis laboratory findings|Laboratory Findings]] | [[Acrocyanosis electrocardiogram|Electrocardiogram]] | [[Acrocyanosis chest x ray|X Rays]] | [[Acrocyanosis CT|CT]] | [[Acrocyanosis MRI|MRI]] | [[Acrocyanosis echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Acrocyanosis other imaging findings|Other Imaging Findings]] | [[Acrocyanosis other diagnostic studies|Other Diagnostic Studies]] | |||
[[ | |||
[[ | |||
==Treatment== | |||
[[Acrocyanosis medical therapy|Medical Therapy]] | [[Acrocyanosis primary prevention|Primary Prevention]] | [[Acrocyanosis secondary prevention|Secondary Prevention]] | [[Acrocyanosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acrocyanosis future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Acrocyanosis case study one|Case #1]] | |||
{{Circulatory system pathology}} | |||
[[Category:Medical signs]] | [[Category:Medical signs]] | ||
Line 97: | Line 48: | ||
[[Category:Physical examination]] | [[Category:Physical examination]] | ||
{{WH}} | |||
{{WS}} | |||
[[fr:Acrocyanose]] | |||
[[pt:Acrocianose]] | |||
Latest revision as of 19:07, 22 June 2013
Acrocyanosis | |
Hand: Acrocyanosis: Gross, an excellent example Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology |
Acrocyanosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Acrocyanosis On the Web |
American Roentgen Ray Society Images of Acrocyanosis |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Cassirer syndrome; Crocq disease
Overview
Historical Perspective
Classifications
Pathophysiology
Causes
Differentiating Acrocyanosis from other Disorders
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Rays | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies